Cancer Staging and Why It Determines Surgery

Cancer staging classifies the size, location, and spread of cancer (Stages 0-IV) using the TNM system Tumor size, Node involvement, and Metastasis. This process is critical because it dictates whether surgery is appropriate for curative, palliative, or diagnostic purposes, determining if a tumor can be resected (removed) or if systemic treatment is needed first

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “staging isn’t just a number we assign, it’s a clinical picture that tells us whether the disease is still within reach surgically and what we can realistically offer the patient at that point.”

Staging combines imaging, biopsy results and sometimes surgical findings to build the most accurate picture possible of how far the disease has progressed.

• Imaging Assessment: CT scans, MRI and PET scans map the tumour’s size, location and whether it has reached nearby structures or distant organs, giving the surgical team a baseline before any decision about operating is made.
• Pathological Staging: Once a biopsy confirms the cancer type and grade, that information combines with imaging to produce a clinical stage, and in some cases the final stage can only be confirmed after surgery when lymph nodes and surrounding tissue are examined properly.
• TNM Classification: Most solid tumour cancers are staged using a system that scores tumour size, node involvement and distant spread separately, and it’s the combination of those three scores rather than any single factor that determines the overall stage and what laparoscopic cancer surgery or other approaches can realistically achieve.
• Staging Surgery: When scans aren’t enough to confirm spread, a surgical staging procedure physically examines the peritoneum, lymph nodes or surrounding structures to fill in the gaps that imaging simply cannot resolve with enough certainty to plan treatment around.

Staging isn’t a one-time event for every cancer type  some cancers get restaged after initial treatment to see whether the disease has responded well enough to change what’s surgically possible next.

The stage isn’t just background information. It’s the primary variable that shapes what the surgical team can offer and in what order.

• Early Stage Cancers: When disease is confined to the primary site and hasn’t reached lymph nodes or distant organs, surgery with clear margins is usually the first and most important step because the realistic chance of removing the problem entirely is at its highest.
• Locally Advanced Disease: A tumour that has grown into surrounding structures or involved regional lymph nodes may not be safely resectable straight away, which is why chemotherapy or radiation often runs first to shrink it before robotic cancer surgery becomes technically possible with acceptable margins.
• Borderline Resectable Cases: Some tumours sit right on the edge of what’s operable, close to a major vessel or involving a critical structure, and the staging findings are what the tumour board uses to decide whether surgery should be attempted or whether a non-operative approach gives the patient a better outcome.
• Stage 4 Disease: Distant spread doesn’t automatically rule out surgery but it fundamentally changes its intent curative resection is rarely on the table but palliative surgery to relieve obstruction, control bleeding or reduce tumour burden can still make a meaningful difference to the patient’s quality of life.

Staging and surgical planning are inseparable, and for a clearer account of how different cancer surgeries are approached once staging is confirmed, cancer surgery is covered separately.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery with a fellowship in Laparoscopic and Robotic Onco-Surgery and 24 years of experience translating staging findings into surgical decisions across a wide range of cancer types and presentations. He leads cancer surgery and Robotic Surgery at KIMS Hospital, Bangalore and heads Oncology Services across Karnataka, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients with complex staging findings, borderline resectable tumours or cases that other centres have found difficult to categorise are assessed here with every operative decision going through full tumour board review. Call +91 8104310753 to book your consultation.

Reference links:

1. National Cancer Institute — Cancer Staging
2. National Institutes of Health — TNM Classification and Surgical Planning

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.